St. Jude Medical, Inc.
Celebrating 30 Years of Innovation in Neuromodulation, St. Jude Medical Unveils Latest Product at American Academy of Pain Medicine Annual Meeting
Published in Medical Letter on the CDC and FDA, February 21st, 2010
St. Jude Medical, Inc. (NYSE:STJ) announced the U.S. Food and Drug Administration (FDA) clearance of the Swift-Lock™ anchor, a new product designed to help physicians efficiently secure neurostimulation leads utilized in spinal cord stimulation (SCS) therapy for the management of chronic pain. Introduced at the American Academy of Pain Medicine (AAPM) annual meeting, the Swift-Lock anchor builds on a 30-year history of developing industry-leading neurostimulation products.
Designed to reduce anchoring time and enhance procedural efficiency, the Swift-Lock anchor eliminates the need for sutures or medical adhesive typically required to secure the anchor to the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- American Journal of Pathology
Of swine, birds and men -- pandemic H1N1 flu - Angiology
Study results from D. Calcagno and colleagues broaden understanding of angiology - Health Discovery Corporation
Vermillion Pays Health Discovery Corporation Final Patent Infringement Settlement Payment - MedImmune
Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics' - Pervasis Therapeutics, Inc.
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel - Pharmaceuticals
Data on pharmaceuticals detailed by S.R. Taylor and co-authors - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
